Cancer Family
Malignant Neoplasm
CI-CAN-00000025CAExplore in graph →
20,116 active trials259 approved drugs3,741 evidence items
Loading cancer entity…
Cancer Family
CI-CAN-00000025CAExplore in graph →
Clinical trials
90,685 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (11,163)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04440436 | Assessment of Safety and Efficacy of IM19 for Recurrent or Refractory (R/R) Non-Hodgkin's Lymphoma(NHL) Patients | recruiting | Phase 1 / Phase 2 | 52 | Beijing Immunochina Medical Science & Technology Co., Ltd.INDUSTRY | 1 | Dec 8, 2020 | clinicaltrials |
| NCT04646759 | Fulvestrant or Capecitabine Combined With Pyrotinib in HR+/HER2+ Metastatic Breast Cancer | recruiting | Phase 3 | 516 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 |
| Nov 30, 2020 |
| clinicaltrials |
| NCT04595929 | Oncological Benefits of Pressured Intraperitoneal Aerosol Chemotherapy (PIPAC) in Patients With T3-4 Gastric Cancer Cyt-(GASPACCO) | recruiting | N/A | 304 | St. Petersburg State Pavlov Medical UniversityOTHER | 1 | Nov 25, 2020 | clinicaltrials |
| NCT03692429 | alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells(alloSHRINK) | recruiting | Phase 1 | 49 | Celyad Oncology SAINDUSTRY | 2 | Nov 20, 2020 | clinicaltrials |
| NCT02878434 | Fertility Preservation in Young Women With Cancer | recruiting | — | 2,000 | University Hospital, GasthuisbergOTHER | 2 | Nov 18, 2020 | clinicaltrials |
| NCT03825861 | Neoadjuvant FOLFIRINOX in the Treatment of Locally Advanced Gastric Cancer(FOLFIRINOX) | recruiting | Phase 2 | 27 | Instituto do Cancer do Estado de São PauloOTHER | 1 | Nov 10, 2020 | clinicaltrials |
| NCT04603872 | CAR-T Cells Combined With Dasatinib for Patients With Relapsed and/or Refractory B-cell Hematological Malignancies | recruiting | Early Phase 1 | 120 | Zhejiang UniversityOTHER | 1 | Oct 28, 2020 | clinicaltrials |
| NCT04532203 | A Study of CAR-T Cells Therapy for Patients With Relapsed and/or Refractory Central Nervous System Hematological Malignancies | recruiting | Early Phase 1 | 72 | Zhejiang UniversityOTHER | 1 | Oct 26, 2020 | clinicaltrials |
| NCT04532281 | A Study of Murine CD19 CAR-T Therapy for Patients With Relapsed or Refractory CD19+ B-cell Hematological Malignancies | recruiting | Early Phase 1 | 120 | Zhejiang UniversityOTHER | 1 | Oct 26, 2020 | clinicaltrials |
| NCT01704716 | High Risk Neuroblastoma Study 1.8 of SIOP-Europe (SIOPEN) | recruiting | Phase 3 | 3,300 | St. Anna KinderkrebsforschungOTHER | 20 | Oct 23, 2020 | clinicaltrials |
| NCT03591276 | Phase 1b Study of Pegylated Liposomal Doxorubicin and Pembrolizumab in Endocrine-resistant Breast Cancer(KEYDOX) | recruiting | Phase 1 / Phase 2 | 15 | Shaare Zedek Medical CenterOTHER | 1 | Oct 23, 2020 | clinicaltrials |
| NCT03315546 | Radiotherapy Delivery in Deep Inspiration for Pediatric Patients(TEDDI) | recruiting | Phase 1 / Phase 2 | 25 | Rigshospitalet, DenmarkOTHER | 2 | Oct 9, 2020 | clinicaltrials |
| NCT04448522 | Reduced vs Conventional Dosage Intensity-modulated Radiotherapy for Chemotherapy-sensitive Stage II-III Nasopharyngeal Carcinoma | recruiting | Phase 3 | 508 | Sun Yat-sen UniversityOTHER | 2 | Sep 28, 2020 | clinicaltrials |
| NCT04453813 | Toripalimab Plus Concurrent Chemo-radiotherapy for Unresectable Locally Recurrent Nasopharyngeal Carcinoma | recruiting | Phase 3 | 226 | Sun Yat-sen UniversityOTHER | 1 | Sep 28, 2020 | clinicaltrials |
| NCT04453826 | Concurrent and Adjuvant PD1 Treatment Combined With Chemo-radiotherapy for High-risk Nasopharyngeal Carcinoma | recruiting | Phase 3 | 388 | Sun Yat-sen UniversityOTHER | 1 | Sep 28, 2020 | clinicaltrials |
| NCT02657785 | Treatment of PCNSL With R-IDARAM and Intrathecal Immunochemotherapy | recruiting | Phase 2 / Phase 3 | 100 | Navy General Hospital, BeijingOTHER | 1 | Sep 9, 2020 | clinicaltrials |
| NCT02836158 | Therapeutic Effects of R-IDARAM and Intrathecal Immunochemotherapy on Elderly Patients With PCNSL | recruiting | Phase 2 / Phase 3 | 100 | Navy General Hospital, BeijingOTHER | 1 | Sep 9, 2020 | clinicaltrials |
| NCT03288532 | Renal Adjuvant MultiPle Arm Randomised Trial(RAMPART) | recruiting | Phase 3 | 1,750 | University College, LondonOTHER | 1 | Sep 7, 2020 | clinicaltrials |
| NCT04220749 | Radiotherapy vs. Trans-Oral Surgery for HPV-Negative Oropharyngeal Squamous Cell Carcinoma | recruiting | Phase 2 | 68 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sOTHER | 1 | Sep 4, 2020 | clinicaltrials |
| NCT04522687 | Influence of Radiotherapy and Chemotherapy in the Value of Peripheral Blood Lymphocyte Subsets Among Thoracic Cancer | recruiting | — | 500 | Shanghai Cancer Hospital, ChinaOTHER | 1 | Aug 21, 2020 | clinicaltrials |
| NCT04493723 | Serial Tumour Biopsies and Blood Biomarkers in Melanoma | recruiting | — | 300 | The Christie NHS Foundation TrustOTHER | 1 | Jul 30, 2020 | clinicaltrials |
| NCT04484064 | Optimization of the Targeted Anticancer Therapies(OpTAT) | recruiting | N/A | 500 | Centre Hospitalier Universitaire VaudoisOTHER | 1 | Jul 23, 2020 | clinicaltrials |
| NCT04481763 | A Study of the Efficacy and Safety of Camrelizumab Plus Radiotherapy for Patients With Early Triple-Negative Breast | recruiting | Phase 1 / Phase 2 | 20 | Jiangxi Provincial Cancer HospitalOTHER | 1 | Jul 22, 2020 | clinicaltrials |
| NCT04481932 | Trastuzumab Combined With Pyrrolidine and Chemotherapy for Locally HER2 Positive Breast Cancer | recruiting | Phase 2 | 104 | Peking UniversityOTHER | 1 | Jul 22, 2020 | clinicaltrials |
| NCT04477967 | Design and Implementation of the Pediatric Liver Transplantation Biobank | recruiting | — | 500 | Children's Hospital of Chongqing Medical UniversityOTHER | 1 | Jul 20, 2020 | clinicaltrials |
| NCT04072653 | Sentinel Node Biopsy Vs Observation After Axillary PET(SOAPET) | recruiting | N/A | 1,528 | Fudan UniversityOTHER | 1 | Jul 13, 2020 | clinicaltrials |
| NCT04150744 | RFA Plus Carrizumab vs Carrizumab Alone for HCC | recruiting | Phase 2 | 120 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Jul 8, 2020 | clinicaltrials |
| NCT03667417 | Genetic Predisposition to Breast and Ovarian Cancer: Prospective Study of BRCAx Gene Mutation(GENEPSO) | recruiting | — | 5,000 | Institut Paoli-CalmettesOTHER | 1 | Jul 1, 2020 | clinicaltrials |
| NCT04453904 | Modality of Adjuvant Radiotherapy and Chemotherapy for Stage Ⅲ Endometrial Cancer | recruiting | N/A | 654 | Peking University People's HospitalOTHER | 1 | Jul 1, 2020 | clinicaltrials |
| NCT04437160 | Adjuvant Chemotherapy for Triple Negative Breast Cancer Patients With Residual Disease After Neoadjuvant Chemotherapy | recruiting | Phase 2 | 286 | Chinese Academy of Medical SciencesOTHER | 1 | Jun 18, 2020 | clinicaltrials |
| NCT04167696 | Study in Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome Patients to Determine the Recommended Dose of CYAD-02(CYCLE-1) | recruiting | Phase 1 | 27 | Celyad Oncology SAINDUSTRY | 2 | Jun 9, 2020 | clinicaltrials |
| NCT04407780 | Cardio-Oncology Registry(CONFUCIUS) | recruiting | — | 5,000 | European Georges Pompidou HospitalOTHER | 1 | May 29, 2020 | clinicaltrials |
| NCT04307901 | Safety Of ColoRectal Assessment and Tumor Evaluation by Colon Capsule Endoscopy(SOCRATEC) | recruiting | — | 600 | Odense University HospitalOTHER | 1 | May 20, 2020 | clinicaltrials |
| NCT03294889 | ONE-SHOT Trial - Ultra-hypofractionated Single-dose SBRT for Prostate Cancer | recruiting | Phase 1 / Phase 2 | 45 | University Hospital, GenevaOTHER | 1 | May 14, 2020 | clinicaltrials |
| NCT04158843 | Radical Local vs. Palliative Therapy for Breast Cancer Patientts With Ipsilateral Humerus or Sternum Oligometastasis(BOMB) | recruiting | N/A | 183 | xuexin heOTHER | 1 | May 12, 2020 | clinicaltrials |
| NCT04281641 | Markers to Evaluate the Efficacy of PH-based Regimen as a Neoadjuvant Therapy for Operable HER2 Positive Breast Cancer(PHC-BC) | recruiting | N/A | 94 | Fudan UniversityOTHER | 1 | May 4, 2020 | clinicaltrials |
| NCT04371042 | PROtocol of Metabolic and Cryptogenic livEr Disease regisTry for intEgration of Omic Studies(PROMETEO) | recruiting | — | 5,000 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | May 1, 2020 | clinicaltrials |
| NCT04365751 | To Compare the Efficacy of Microwave Ablation and Laparoscopic Hepatectomy for Hepatocellular Carcinoma | recruiting | N/A | 1,134 | Chinese PLA General HospitalOTHER | 1 | Apr 28, 2020 | clinicaltrials |
| NCT04356235 | Examining and Comparing the Temporal Changes and Results of Cosmetic, Quality of Life and Patient Satisfaction Achieved With Immediate and Delayed-immediate Implant-based Breast Reconstruction Procedures and Contralateral Symmetrization Techniques | recruiting | — | 528 | National Institute of Oncology, HungaryOTHER | 1 | Apr 22, 2020 | clinicaltrials |
| NCT04349527 | Comparison of the Cosmetic Results, Quality of Life and Patient Satisfaction Achieved With Round-block and Retroglandular Oncoplastic Breast Conserving Surgeries | recruiting | — | 242 | National Institute of Oncology, HungaryOTHER | 1 | Apr 21, 2020 | clinicaltrials |
| NCT04330456 | Combined Treatment of Patients With Soft Tissue Sarcoma Including Preoperative Stereotactic Radiation Therapy and Postoperative Conformal Radiation Therapy | recruiting | N/A | 30 | N.N. Petrov National Medical Research Center of OncologyOTHER | 1 | Apr 1, 2020 | clinicaltrials |
| NCT03793517 | Decitabine Plus mBU/CY for High Risk Acute Leukemia With MRD Pre-HSCT | recruiting | Phase 2 / Phase 3 | 55 | Peking University People's HospitalOTHER | 1 | Mar 10, 2020 | clinicaltrials |
| NCT04286841 | The Real World Study of Neoadjuvant Immunotherapy in Early Stage NSCLC in China | recruiting | — | 100 | Guangdong Association of Clinical TrialsOTHER | 1 | Feb 27, 2020 | clinicaltrials |
| NCT04157569 | CtDNA After Chemotherapy in Elderly Patients With Acute Leukemia | recruiting | — | 200 | Navy General Hospital, BeijingOTHER | 1 | Feb 25, 2020 | clinicaltrials |
| NCT03804320 | Protocol Active Surveillance Small Renal Masses (SRMs) | recruiting | N/A | 180 | IRCCS San RaffaeleOTHER | 1 | Feb 11, 2020 | clinicaltrials |
| NCT04212715 | Prostate SABR With Intra-Prostatic SABR Boost | recruiting | Phase 2 | 30 | King Saud UniversityOTHER | 1 | Jan 2, 2020 | clinicaltrials |
| NCT04209244 | Effect of Fish Oil on Hyperlipidemia and Toxicities in Children and Young Adults With Acute Lymphoblastic Leukemia | recruiting | N/A | 100 | Rigshospitalet, DenmarkOTHER | 1 | Dec 26, 2019 | clinicaltrials |
| NCT04197414 | Development of Urologic Registry for Personalized Medicine in Patients With Urological Malignancy by Analyzing Circulating Tumor DNA | recruiting | — | 3,000 | Yonsei UniversityOTHER | 1 | Dec 13, 2019 | clinicaltrials |
Data updated 23 days agoSource updated Dec 8, 2020source: clinicaltrials